Introduction
Open Access
- 1 April 2008
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 65 (1) , 1-4
- https://doi.org/10.1111/j.1365-2125.2008.03131.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialThe Lancet, 2006
- Co-receptor antagonists as HIV-1 entry inhibitorsCurrent Opinion in Infectious Diseases, 2004
- The chemokine receptor, CCR5The International Journal of Biochemistry & Cell Biology, 2004
- Structured Treatment Interruption in Patients Infected with HIVDrugs, 2002
- Current strategies in the treatment of HIV infection.2001
- Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral TherapyJAMA, 1999
- The role of a mutant CCR5 allele in HIV–1 transmission and disease progressionNature Medicine, 1996
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995